Wamhoff, Eike-Christian
Ronsard, Larance http://orcid.org/0000-0002-5307-1940
Feldman, Jared
Knappe, Grant A. http://orcid.org/0000-0002-5041-2383
Hauser, Blake M. http://orcid.org/0000-0002-0100-1684
Romanov, Anna http://orcid.org/0000-0002-1239-4946
Case, James Brett http://orcid.org/0000-0001-7331-5511
Sanapala, Shilpa
Lam, Evan C.
Denis, Kerri J. St. http://orcid.org/0000-0002-6324-7890
Boucau, Julie http://orcid.org/0000-0001-6731-7238
Barczak, Amy K. http://orcid.org/0000-0003-3806-2381
Balazs, Alejandro B. http://orcid.org/0000-0002-1767-3944
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Schmidt, Aaron G. http://orcid.org/0000-0003-3627-2553
Lingwood, Daniel http://orcid.org/0000-0001-5631-9238
Bathe, Mark http://orcid.org/0000-0002-6199-6855
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R21-EB026008)
National Science Foundation (CBET-1729397, CCF-1956054)
United States Department of Defense | United States Navy | Office of Naval Research (N00014-21-1-4013, N00014-17-1-260)
United States Department of Defense | United States Army | U.S. Army Research, Development and Engineering Command | Army Research Office (W911NF-13-D-0001)
Article History
Received: 26 July 2023
Accepted: 8 January 2024
First Online: 30 January 2024
Competing interests
: The Massachusetts Institute of Technology has filed a patent (US application number 16/752,394) covering the use of DNA origami as a vaccine platform on behalf of the co-inventors (E.-C.W. and M.B.). M.S.D. is a consultant for Inbios, Vir Biotechnology, Moderna, Merck, IntegerBio, and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Emergent BioSolutions, Moderna, Vir Biotechnology, and IntegerBio. D.L. reports SAB membership for Flagship Labs 72, Tendel Therapies, and Lattice Therapeutics Inc. M.B. is co-founder and SAB member of Kano Therapeutics, Inc. and Cache DNA, Inc. The remaining authors declare no competing interests.